2021 State of Revenue for Life Sciences

Revenue management is business critical, yet the majority of executives at pharmaceutical and medtech companies believe their industry could better optimize revenue activities to maximize growth.

Hear from our industry experts as they present reasons for this disconnect and other key insight from the 2021 State of Revenue Report – a compilation of findings from a recent survey of executives who are directly responsible for revenue growth at large life sciences companies. We’ll discuss how revenue management challenges are having an impact on business and how companies are responding. We’ll also uncover the areas that executives view as their biggest opportunities for success.

Topics covered include:

• Preparing for regulatory change under the new administration
• Addressing global pricing-related challenges
• The impact of technology on revenue activities
• Expected business results from better revenue management